Stem cells may hold a key to developing new vaccines against COVID-19
(Elsevier) The SARS-CoV-2 virus that causes COVID-19 may have the ability to reactivate dormant tuberculosis (TB). In a novel study scientists report in The American Journal of Pathology that infection with a specific coronavirus strain reactivated dormant Mycobacterium tuberculosis (MTB) in mice. This knowledge may help to develop new vaccines for COVID-19 and avoid a potential global tuberculosis epidemic.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
More News: Coronavirus | COVID-19 | Epidemics | Epidemiology | Infectious Diseases | Pathology | SARS | Stem Cell Therapy | Stem Cells | Study | Tuberculosis | Vaccines